Clinical presentation, management, and outcomes of post-transplant lymphoproliferative disorder in renal and pancreas transplantation: a 22-year experience
Kian Emami, Jane Norman, Titus Augustine · 2026
Read Clinical presentation, management, and outcomes of post-transplant lymphoproliferative disorder in renal and pancreas transplantation: a 22-year experience by Kian Emami, Jane Norman, Titus Augustine (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13319058.txt.
Description
Kian Emami, Jane Norman, and Titus Augustine report a 2026 retrospective study of post-transplant lymphoproliferative disorder at a Manchester transplant centre. The dangerous overgrowth follows long immune suppression and often Epstein-Barr virus activity. Records covered 73 kidney and pancreas transplant patients diagnosed between 2002 and 2025.
Diagnosis came a median of 132 months after transplant. Over half the cases appeared more than ten years out. The commonest type was a diffuse large B-cell lymphoma pattern. Belly symptoms and general B symptoms led presentations. Bleeding or anaemia significantly tracked with slower diagnosis. Remission, full or partial, was achieved in 75 percent of patients. Five-year survival reached 68 percent in the cohort. The authors want faster referral routes and a national registry.
Catalog record
| CREATOR | Kian Emami, Jane Norman, Titus Augustine |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43325 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |